New and emerging combination therapies for esophageal cancer
Esophageal cancer comprises two different histological forms – squamous cell carcinoma (SCC) and adenocarcinoma (AC). While the incidence of AC has increased steeply in Western countries during the last few years, the incidence of SCC is fairly stable. Both forms differ in pathogenesis and response...
Main Authors: | Wiedmann, Marcus W, Mössner, Joachim |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706320/ |
Similar Items
-
Safety and Efficacy of Sunitinib in Patients with Unresectable Pancreatic Neuroendocrine Tumors
by: Wiedmann, Marcus W., et al.
Published: (2012) -
Palliative Endoscopic Therapy of Esophageal Cancer
by: Rabenstein, Thomas
Published: (2015) -
Cervical Esophageal Hemangioma Combined with Thyroid Cancer
by: Lee, Jong Cheol, et al.
Published: (2011) -
Advances in targeted therapies and new promising targets in esophageal cancer
by: Belkhiri, Abbes, et al.
Published: (2015) -
Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma
by: Wang, Huan-Huan, et al.
Published: (2015)